Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.97
(
1.04%
)
US TECH 100
26,685.20
(
0.84%
)
Dow Jones
49,695.49
(
1.71%
)
Brent Oil
110.07
(
-2.06%
)
Bitcoin
76,407.56
(
0.83%
)
News Focus
News Focus
Post# of 48105
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 928
Posts 158817
Boards Moderated 2
Alias Born 08/13/2010

BottomBounce

Member Level

Re: shakerzzz post# 29626

Thursday, 12/05/2013 6:28:01 AM

Thursday, December 05, 2013 6:28:01 AM

Post# of 48105
$DNDN. PROVENGE® (sipuleucel-T) is approved by the FDA as an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer. http://www.provenge.com/

I'm not a financial advisor. All of my posts are for entertainment purposes only and based on my opinion. Advice: Do your own DD and always only invest money you can afford to lose. GLTA

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today